Rationale for the Use of Nonabsorbable Antibiotics in the Treatment of Urinary Infections: Follow-Up Report

  • Herbert Schwartz


Gram-negative bacteria, particularly those that comprise the loosely termed coliform group, are responsible for 70–80% of urinary infections(1–4). This is true for patients in a domiciliary as well as a hospital practice(5,6), through the frequency of infecting organisms varies considerably between these two groups.


Rheumatic Fever Urinary Infection Urethral Catheter Phenyl Ethyl Alcohol Recurrent Urinary Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Campbell, M. F., Urology, W. B. Saunders Company, Philadelphia, Vol. 1, pp. 381–405, 1963.Google Scholar
  2. 2.
    Beeson, P. B. Factors in the pathogenesis of pyelonephritis. Yale J. Biol. Med. 28: 81–104, 1955.PubMedGoogle Scholar
  3. 3.
    Bush, I. M., Orkin, L. A., and Winter, J. An eleven year study of urinary bacterial cultures in a total in-patient hospital population. J. Urol. 94: 168–171, 1965.PubMedGoogle Scholar
  4. 4.
    Schwarz, H., Schirmer, H., Ehlers, B., and Post, B. Urinary tract infections: Correlation between organisms obtained simultaneously from the urine and feces of patients with bacteriuria and pyuria. J. Urol. 101: 756–767, 1969.Google Scholar
  5. 5.
    O’Grady, F., and Brumfitt, W. Urinary Tract Infection, Oxford University Press, London, pp. 68–79, 1968.Google Scholar
  6. 6.
    Kunin, C. M., Deutscher, R., and Paquin A. Urinary tract infection in school children: An epidemiological, clinical, and laboratory study. Medicine 43: 91–130, 1964.PubMedGoogle Scholar
  7. 7.
    Schwarz, H., Schirmer, H., Post, B., and Ehlers, B. Correlation of Escherichia coil occurring simultaneously in the urine and stool of patients with clinically significant bacteriuria: Serotyping with group-specific O antisera. J. Urol. 101: 379–382, 1969.PubMedGoogle Scholar
  8. 8.
    Poth, E. J., and Ross, C. A. The clinical use of phthalylsulfathiazole. J. Lab. Clin. Med. 29: 785–808, 1944.Google Scholar
  9. 9.
    Everett, H. S., Vosberg, G. A., and Davis, J. M. The treatment of urinary infections with sulfathalidine (phthalylsulfathiazole). J. Urol. 59: 83–91, 1948.PubMedGoogle Scholar
  10. 10.
    Everett, H. S., Scott, R. B., and Steptoe, P. P. The treatment of urinary infections with sulfasuxidine (succinylsulfathiazole). Am. J. Obstet. Gynec. 49: 114–127, 1945.Google Scholar
  11. 11.
    Ewing, W. H. Isolation and Identification of E. coli Serotypes Associated with Diarrhea! Diseases, CDC Laboratory Manual, U.S. Dept. H.alth, Education and Welfare, Public Health Service, Communicable Disease Center, Laboratory Branch, Atlanta, Georgia, p. 10, 1963.Google Scholar
  12. 12.
    Schwarz, H. Renal invasion by E. colivia mucosal lesion of the sigmoid colon: A demonstration utilizing methods of autoradiography and group-specific serologic typing. Invest. Urol. 6: 98–113, 1968.PubMedGoogle Scholar
  13. 13.
    Poth, E. J. Sulfasuxidine and sulfathalidine. Texas Rep. Biol. Med. 4: 68–102, 1946.Google Scholar
  14. 14.
    Goodman, L. S., and Gillman, A. The Pharmacological Basis of Therapeutics. Macmillan, New York, pp. 1158–1160, 1965.Google Scholar

Copyright information

© Plenum Press, New York 1972

Authors and Affiliations

  • Herbert Schwartz
    • 1
  1. 1.The James Buchanan Brady Urological InstituteThe Johns Hopkins HospitalBaltimoreUSA

Personalised recommendations